Drug shortages impact real patients each day. That’s why we’re proud to represent the patient voice in three critical CMS comment letters aimed at building a more reliable, resilient drug supply.
At Angels for Change, advocacy means action. Through collaboration and engagement with leading partners—including the Duke-Margolis Institute for Health Policy, the End Drug Shortages Alliance (EDSA), and the USP Drug Shortage Task Force—we are ensuring that solutions both practical and grounded in real patient needs.
Patients and Providers deserve a better supply chain. We boldly to stand alongside these leaders, amplifying patient experiences to push forward meaningful, lasting change. Because when patients are centered in every decision, we can end drug shortages and improve care for all.
Read the Letters:
Duke-Margolis Institute for Health Policy Letter:
EDSA Letter:
USP Letter:
At Angels for Change, we bring together patients, policymakers, and industry leaders to solve drug shortages at their source. But we can’t do it alone.
Your support powers the partnerships and advocacy that make a more reliable drug supply possible. Support this life-saving work.
